EUVIMEDEUVIMED entdecken
Crossref

Discovery of natural‐derived M pro inhibitors as therapeutic candidates for COVID‐19: Structure‐based pharmacophore screening combined with QSAR analysis

Mohammad A Khanfar, Nada Salaas, Reem Abumostafa

Molecular Informatics · 2023-04 · 42 (4)

DOI: 10.1002/minf.202200198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Informatics, online erschienen am 10.02.2023. Verfasst von Mohammad A Khanfar und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Alfaisal University, Al Takhassusi Rd, P. O. Box 50927, Riyadh, 11533, Saudi Arabia. Hauptthemen laut MEDLINE: COVID-19, Biological Products. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: College of Pharmacy and Office of Research and Innovation (ORI) at Alfaisal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main protease (M pro ) is an essential enzyme for the life cycle of SARS‐CoV‐2 and a validated target for treatment of COVID‐19 infection. Structure‐based pharmacophore modeling combined with QSAR calculations were employed to identify new chemical scaffolds of M pro inhibitors from natural products repository. Hundreds of pharmacophore models were manually built from their corresponding X‐ray crystallographic structures. A pharmacophore model that was validated by receiver operating characteristic (ROC) curve analysis and selected using the statistically optimum QSAR equation was implemented as a 3D‐search tool to mine AnalytiCon Discovery database of natural products. Captured hits that showed the highest predicted inhibitory activities were bioassayed. Three active M pro inhibitors (pseurotin A, lactupicrin, and alpinetin) were successfully identified with IC 50 values in low micromolar range.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Biological ProductsHumansModels, MolecularPharmacophoreQuantitative Structure-Activity RelationshipSARS-CoV-2

Stichwörter der Autor:innen

MproQSARSARS-CoV-2natural productspharmacophore

Substanzen

Biological Products

Autor:innen und Institutionen

  • College of Pharmacy, Alfaisal University, Al Takhassusi Rd, P. O. Box 50927, Riyadh, 11533, Saudi Arabia.
  • Department of Pharmaceutical Sciences, Faculty of Pharmacy, The University of Jordan, P.O Box 13140, Amman, 11942, Jordan.

Förderung

  • College of Pharmacy and Office of Research and Innovation (ORI) at Alfaisal University

Zitieren

APA

Khanfar, M. A., Salaas, N., & Abumostafa, R. (2023). Discovery of natural‐derived M pro inhibitors as therapeutic candidates for COVID‐19: Structure‐based pharmacophore screening combined with QSAR analysis. Molecular Informatics, 42(4). https://doi.org/10.1002/minf.202200198

Vancouver

Khanfar MA, Salaas N, Abumostafa R. Discovery of natural‐derived M pro inhibitors as therapeutic candidates for COVID‐19: Structure‐based pharmacophore screening combined with QSAR analysis. Molecular Informatics. 2023;42(4). doi:10.1002/minf.202200198

BibTeX
@article{Khanfar2023,
  author = {Khanfar, Mohammad A and Salaas, Nada and Abumostafa, Reem},
  title = {Discovery of natural‐derived M pro inhibitors as therapeutic candidates for COVID‐19: Structure‐based pharmacophore screening combined with QSAR analysis},
  journal = {Molecular Informatics},
  year = {2023},
  volume = {42},
  number = {4},
  doi = {10.1002/minf.202200198}
}
Kostenlos starten →